This topic contains a solution. Click here to go to the answer

Author Question: To incorporate repeated measures in a single-case design, it is important that the behavior is a) ... (Read 46 times)

kwoodring

  • Hero Member
  • *****
  • Posts: 560
To incorporate repeated measures in a single-case design, it is important that the behavior is
 
  a) reliable
 b) varied.
 c) valid.
 d) subjective.

Question 2

A pharmaceutical company develops a new drug that increases the availability of norepinephrine in the brainstem and right frontal lobe. Which of the following effects would you expect the drug to have?
 
  a) Improving alertnes
 b) Improving spotlight attention
 c) Improving executive attention
 d) Improving selective attention



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

janeli

  • Sr. Member
  • ****
  • Posts: 346
Answer to Question 1

A

Answer to Question 2

A




kwoodring

  • Member
  • Posts: 560
Reply 2 on: Jun 20, 2018
Great answer, keep it coming :)


rachel

  • Member
  • Posts: 323
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

Malaria mortality rates are falling. Increased malaria prevention and control measures have greatly improved these rates. Since 2000, malaria mortality rates have fallen globally by 60% among all age groups, and by 65% among children under age 5.

Did you know?

When intravenous medications are involved in adverse drug events, their harmful effects may occur more rapidly, and be more severe than errors with oral medications. This is due to the direct administration into the bloodstream.

Did you know?

The lipid bilayer is made of phospholipids. They are arranged in a double layer because one of their ends is attracted to water while the other is repelled by water.

Did you know?

The term pharmacology is derived from the Greek words pharmakon("claim, medicine, poison, or remedy") and logos ("study").

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library